Masao Harada - Concepedia

Author

Masao Harada

National Hospital Organization Hokkaido Medical Center

Also Known As

M Harada, MASAO HARADA, Masao HARADA, Masao Harada

116

Publications

8.8K

Citations

H-Index

Concepts

All Affiliations

National Hospital Organization Hokkaido Medical Center Sapporo National Hospital Hokkaido University NTT Medical Center Sapporo Medical University

About

Masao Harada is an author at National Hospital Organization Hokkaido Medical Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.5K
2	Pathology	12	13	1.2K
3	Health Sciences	3	3	321
4	Cell Biology	2	2	79
5	Immunology	1	1	66

Masao Harada

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, New England Journal of Medicine	2010	5.5K
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Takashi Seto, Katsuyuki Kiura, Makoto Nishio, The Lancet Oncology Non-small-cell Lung CancerMedicinePathologyAf-001jp StudyBronchial Neoplasm	2013	576
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura, Journal of Clinical Oncology	2008	364
Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301 Sayaka Onoda, Noriyuki Masuda, Takashi Seto, Journal of Clinical Oncology	2006	226
Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q Satoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, Journal of Thoracic Oncology	2014	199
Diagnostic Value of Endobronchial Ultrasonography With a Guide Sheath for Peripheral Pulmonary Lesions Without X-Ray Fluoroscopy Motoko Yoshikawa, Noriaki Sukoh, Koichi Yamazaki, CHEST Journal Endobronchial UltrasonographyMedical ImagingPneumothoraxMultiple Pulmonary NoduleGuide Sheath	2007	184
First-Line Gefitinib in Patients Aged 75 or Older With Advanced Non–Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: NEJ 003 Study Makoto Maemondo, Yuji Minegishi, Akira Inoue, Journal of Thoracic Oncology Patients Aged 75MedicineFirst-line GefitinibPathologyCancer Genomics	2012	154
Clinical characteristics of pleomorphic carcinoma of the lung Kenichiro Ito, Satoshi Oizumi, Shinichi Fukumoto, Lung Cancer MedicinePathologyBronchial NeoplasmPulmonary BlastomaPleomorphic Carcinoma	2009	127
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study Kaoru Kubota, Toyoaki Hida, Satoshi Ishikura, The Lancet Oncology Radiation TherapyMedicineRandomised Phase 3Thoracic RadiotherapyCancer Treatment	2013	115
Quality of Life with Gefitinib in Patients with <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial Satoshi Oizumi, Kunihiko Kobayashi, Akira Inoue, The Oncologist	2012	101

Page 1